Skip to main content
!
Phase III+: The University is open for expanded research operations; only authorized personnel will be admitted on campus. More info here.

The Rockefeller University releases statement concerning Knut Wittkowski

The opinions that have been expressed by Knut Wittkowski, discouraging social distancing in order to hasten the development of herd immunity to the novel coronavirus, do not represent the views of The Rockefeller University, its leadership, or its faculty.

Rockefeller scientists launch a broad range of studies into novel coronavirus

Over 130 scientists in 18 labs are conducting research to advance the development of new, urgently needed approaches for the prevention and treatment of COVID-19.

>

Elaine Fuchs awarded 2020 Canada Gairdner International Award for Biomedical Science

Fuchs, a world leader in the study of skin biology, is being recognized for revealing the molecular mechanisms by which skin stem cells make and repair tissues.

How skin cells embark on a swift yet elaborate death

Scientists have identified the mechanism that allows skin cells to sense changes in their environment, and very quickly respond to reinforce the skin's outermost layer. The findings provide insight into how errors in this process might lead to skin conditions like psoriasis.  

Research on soldier ants reveals that evolution can go in reverse

Turtle ant soldiers and their oddly-shaped heads suggest that evolution is not always a one-way street toward increasing specialization.

>

Paul Muller wins 2020 Weintraub Graduate Student Award

Muller receives the honor for his examination of the interactions between neurons in the intestinal tract, known as enteric neurons, and intestinal macrophages, a kind of immune cell.

Rockefeller gets a new, more efficient boiler

With the aid of a mobile crane and a crew of around 20, a fully assembled Cleaver Brooks Fire Tube boiler was delivered into the university’s Power House. This winter, after months of work to plumb, wire, and test the machine, it was lit for the first time and began providing heat to Rockefeller buildings.

When zombies take over the brain 

Research on Parkinson’s has taken a surprising twist. A group of neurons long assumed to expire in the disease were recently found to not be dead after all—providing a possible explanation for how the condition worsens.

Rockefeller grants commercial license for the development of new HIV drugs

The novel compounds are based on so-called broadly neutralizing antibodies, molecules that make rare people's immune systems capable of fighting HIV. They could potentially yield new treatment and prevention approaches benefitting people around the world, including in developing countries.

The Tri-Institutional Therapeutics Discovery Institute renews partnerships with Takeda and Bridge Medicines

The renewal allows Rockefeller faculty to continue transforming their discoveries into new medicines.

Recent Awards and Honors

Junyue Cao

Junyue Cao wins Science & SciLifeLab Grand Prize For Young Scientists

November 19, 2020

Cao is recognized for his work using single-cell genomic methods to enable developmental mapping of entire organisms, described in an essay published in Science.
LLuciano Marraffini portrait

Luciano Marraffini awarded Max Planck-Humboldt Medal

October 14, 2020

Marraffini receives the award for his achievements studying CRISPR-Cas, a bacterial immune mechanism whose discovery led to modern gene-editing tools.
More awards and honors

Rockefeller in the News

Nature News

An innovative approach from Priya Rajasethupathy has been used to link genetics to behavior in mice. The analysis identifies a gene that underpins the role of the brain’s thalamus region in maintaining short-term memory.

NBC News

Research led by Jean-Laurent Casanova shows Covid-19 patients with life-threatening illness have antibodies that disable key immune system proteins called interferons.

Knowable Magazine

Just how sick we get from COVID-19 depends on genetic variations, including ones that sabotage immune molecules called interferons. Jean-Laurent Casanova's work aims to better understand why, which could lead to new treatments for COVID-19 and other scourges.

Seek magazine

Rockefeller’s flagship publication is interested not just in scientific results, but in the people, ideas, and conversations that ignite discovery. The latest issue takes us inside the response to the pandemic, where scientists are using every tool in the 21st century playbook to transform COVID-19 into a manageable disease. Also: Mosquito menace, The brain inside your gut, and Addiction then and now.


From this issue

 


Subscribe to Rockefeller Science News

Did you know Rockefeller has a monthly science newsletter? Subscribe now to stay on top of the latest discoveries, news updates, and science highlights from Rockefeller’s laboratories and researchers.